The world knows Martin Shkreli mostly for his controversial decision to crank up the price of an essential drug by 5,000 percent, earning him the moniker “Pharma Bro.” On Sunday, his Twitter account was suspended following a series of harassment Tweets directed at a female journalist.
The journalist in question is Lauren Duca and according to unnamed sources, she has been the subject of unwanted attention from Shkreli for several days, Boston Globe reports. The whole thing reportedly started after Duca’s appearance at a Fox News show hosted by Tucker Carlson where the two butted heads.
Before coming on, Duca had written a scathing article titled “Donald Trump is gaslighting America,” which was published in Teen Vogue. The Fox News host didn’t take kindly to how the president-elect was portrayed and made it known. After appearing on the show, Duca received numerous threats. Several days later, Shkreli started Tweeting the journalist with suggestive comments.
In one post, Shkreli asked Duca to be his plus-one during Trump’s inauguration, to which she responded by Tweeting “I would rather eat my own organs.” The pharmaceutical executive followed that up by posting photoshopped images of him and Duca, which the latter found inappropriate.
As a result of his actions, Twitter decided that it would be better for Shkreli to take some time off the micro-blogging service, confirming his suspension to the media via email. After the suspension, Duca made her own Tweet, wondering at how women immediately get harassed the moment they start getting attention for their work, Reuters reports.
"Why is harassment an automatic career hazard for a woman receiving any amount of professional attention?" Duca’s Tweet reads.
Considering what Shkreli is known to have done, which led to his dismissal as head of Turing Pharmaceuticals, this news might seem benign in comparison. However, it is indicative of a habit by “Pharma Bro” to not care about what anyone thought of his actions.


Meta AI Strategy Faces Challenges as Zuckerberg Admits Mistakes in Internal Memo
ByteDance Eyes Iluvatar, Baidu AI Chips Amid China’s AI Push
SpaceX IPO Sparks Market Optimism as Shares Surge 19% on Trading Debut
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race
UK Banks Report Surge in APP Fraud Losses as Pressure Mounts on Meta and Tech Platforms
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation
US Raises Concerns Over Possible ASML EUV Machine Transfer to China
SpaceX Stock Soars After Historic IPO, Reaches $2.5 Trillion Market Value
OpenAI's $34B Spending Pushes AI Market Leadership Ahead of IPO
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions
Anthropic Officials Meet White House Over AI Model Outage
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 



